Work

Abstract 5624: The antiviral, Daclatasvir, disrupts ASCL1-EZH2 signaling and impairs survival of neuroendocrine prostate cancer cells

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-5624

Authors: Rohith Guddeti, Jitender Monga, Craig Rogers, Dhananjay Chitale, Shirish Gadgeel, Jagadananda Ghosh

Institution: Henry Ford Health

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409632667

Cites:

Cited by:

Related to: 10